Published in Semin Oncol on June 01, 1987
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol (1997) 4.51
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia (2000) 3.32
Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med (1988) 2.44
Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci U S A (1988) 2.42
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res (1998) 2.33
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood (1993) 2.12
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res (1996) 1.99
Clonal hematopoiesis demonstrated by X-linked DNA polymorphisms after allogeneic bone marrow transplantation. N Engl J Med (1989) 1.89
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? Blood (1992) 1.77
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol (1997) 1.75
Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol (1991) 1.61
The human hematopoietic stem cell in vitro and in vivo. Blood Cells (1992) 1.58
The hematologic complications following partial gastrectomy. A study of 292 patients. Am J Med (1967) 1.55
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res (1994) 1.54
Graft-versus-host disease in a liver transplant recipient. Ann Intern Med (1992) 1.52
Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy. Cancer (1998) 1.52
Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood (1994) 1.51
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA (1999) 1.49
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood (1996) 1.49
Studies on the pathogenesis of alcohol-induced sideroblastic bone-marrow abnormalities. N Engl J Med (1970) 1.47
High-dose cytosine arabinoside therapy for refractory leukemia. Blood (1983) 1.44
Etoposide kinetics in patients with obstructive jaundice. J Clin Oncol (1990) 1.43
Guidelines for systemic therapy of early stage breast cancer. Breast Cancer Res Treat (1997) 1.42
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results. J Clin Oncol (1989) 1.41
Brief report: donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient. N Engl J Med (1993) 1.40
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma. Leuk Lymphoma (1998) 1.39
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant (1992) 1.36
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36
Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest (1978) 1.31
Allogeneic bone marrow transplantation for low-grade lymphoma. Blood (1998) 1.29
Nocardial infections in bone marrow transplant recipients. Clin Infect Dis (1996) 1.28
Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med (1977) 1.27
Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant (1991) 1.27
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant (1998) 1.25
The sideroblastic anemias. Semin Hematol (1970) 1.25
Management of the mildly abnormal Pap smear: a conservative approach. Gynecol Oncol (1985) 1.25
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J Clin Oncol (1996) 1.22
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol (1989) 1.19
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood (1992) 1.19
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med (1981) 1.17
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol (1991) 1.16
Determination of serum and blood pyridoxal phosphate concentrations with purified rabbit skeletal muscle apophosphorylase b. J Lab Clin Med (1969) 1.16
Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells. Blood (2001) 1.16
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant (2001) 1.16
Megaloblastic anemia secondary to folate deficiency associated with hypothyroidism. Ann Intern Med (1968) 1.16
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. Blood (1996) 1.15
Acquired sixth-nerve paresis in children. Arch Ophthalmol (1970) 1.14
Reversible megaloblastic and sideroblastic marrow abnormalities in alcoholic patients. Br J Haematol (1969) 1.14
Varying intensity of postremission therapy in acute myeloid leukemia. Blood (1992) 1.13
Neuropathology of experimental vitamin B12 deficiency in monkeys. Neurology (1976) 1.13
Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant (1998) 1.13
An ultrastructural study of subacute combined degeneration of the spinal cord in vitamin B12-deficient rhesus monkeys. J Neuropathol Exp Neurol (1978) 1.11
Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients. Cancer Res (1984) 1.11
Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide B. J Lab Clin Med (1970) 1.10
Improved storage of platelets for transfusion in a new container. Blood (1982) 1.09
Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood (1978) 1.07
Toxic epidermal necrolysis in a patient with graft-vs-host reaction. Arch Dermatol (1972) 1.07
The excretion of foriminoglutamic acid and urocanic acid after partial gastrectomy. Lancet (1966) 1.07
Graft-versus-host disease. Morphologic variation and differential diagnosis in 8 cases of HL-A matched bone marrow transplantation. Am J Pathol (1971) 1.06
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia. Lancet (1984) 1.06
Facilitated light microscopic cytochemical diagnosis of acute myelogenous leukemia. Cancer Res (1979) 1.05
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group. Bone Marrow Transplant (2000) 1.05
Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol (1991) 1.04
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood (1996) 1.04
Platelet transfusion and survival in adults with acute leukemia. Leukemia (2007) 1.03
Computer-assisted audits of blood component transfusion. Cleve Clin J Med (1989) 1.03
Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator. Transfusion (1971) 1.02
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol (1999) 1.02
T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients. J Clin Oncol (1995) 1.01
Graft-versus-host reaction complicating HL-A matched bone-marrow transplantation. Lancet (1970) 1.01
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood (1992) 1.00
Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study. Ann Neurol (1983) 1.00
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. J Clin Oncol (2001) 0.99
Metastatic squamous cell carcinoma of the skin. J Natl Med Assoc (1980) 0.98
FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood (1996) 0.98
Energy-dispersive X-ray analysis of the mitochondria of sideroblastic anaemia. Br J Haematol (1980) 0.98
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study. Cancer (1983) 0.97